New insulin safety guidance

Printer-friendly version Printer Friendly Version
Email Story Send This Story

July 2010
The National Patient Safety Agency (NPSA) has issued guidance for all NHS organisations across England and Wales aimed at reducing the number of wrong dose incidents involving insulin.

The Rapid Response Report, produced by the NPSA in conjunction with key stakeholders and NHS organisations across England and Wales, is as a response to 3,881 patient safety incidents reported between 2004 and 2009.

These included one death and one case of severe harm that occurred after clinicians misinterpreted the abbreviation of the term “unit”. A further three deaths and 17 other incidents occurred between January 2005 and July 2009 where an intravenous syringe was used to measure and administer insulin.

The Rapid Response Report asks NHS organisations to ensure that:
• All regular and single insulin (bolus) doses are measured and administered using an insulin syringe or commercial insulin pen device (never using intravenous syringes).
• The term “units” is used in all contexts.Abbreviations, such as “U” or “IU”, are never used.
• A training programme is in place for all healthcare staff that are expected to prescribe, prepare and administer insulin.
• All clinical areas and community staff treating patients with insulin have adequate supplies of insulin syringes and subcutaneous needles.
• NHS Diabetes has developed an e-learning training course on the safer use of insulin to help healthcare professionals implement today’s guidance.
• Insulin safety forms part of the NPSA’s 10 for 2010 improvement programme. This builds on the campaigns Patient Safety First in England and 1000 Lives in Wales and aims to reduce avoidable harm in 10 high risk clinical areas.
• Professor David Cousins, NPSA’s Head of Patient Safety for Medication and Medical Devices, said: “Insulin is a widely used medicine used to treat diabetes.


Anna Morton, Director of NHS Diabetes, said: “NHS Diabetes is pleased to support this guidance and we have launched an online training course for health professionals to support it. Our Safe Use of Insulin website also includes a vast amount of practical information and a number of true stories illustrating the dangers when insulin is used incorrectly. “

For more information about the safe administration of insulin, visit www.nrls.npsa.nhs.uk/alerts or visit the NHS Diabetes website – www.diabetes.nhs.uk/safe_use_of_insulin

 


Printer-friendly version Printer Friendly Version
Email Story Send This Story
Supplier Search
Story Search

FEATURE ARTICLE

Guide to insulin pump therapy
The NHS Technology Adoption Centre aims to encourage the increased use of continuous subcutaneous insulin infusion (CSII), also known as insulin pump therapy, to improve the management of Type 1 diabetes, in line with NICE guidance. HADLEIGH STOLLAR, programme manager, the NHS Technology Adoption Centre, explains how the latest “How to, Why to” guide can support Trusts in managing implementation.

PRODUCT ARTICLE

Fully virucidal alcohol hand gel
ECOLAB, an infection prevention specialist, will be showcasing its new fully virucidal alcohol hand gel, Spirigel Complete. With the theme of “Complete Protection – Everywhere It Matters”, the company will be demonstrating its products and services to the attending delegates.